It was shown that TUBA1C expression was elevated in most tumours, including bladder cancer (BLCA), breast cancer (BRCA), colorectal cancer (COAD), gastric cancer, head and neck cancer (HNSC), kidney cancer, liver cancer (LIHC), lymphoma, melanoma, myeloma, ovarian cancer (OV), pancreatic cancer (PAAD), and sarcoma (SARC). Here, TUBA1C is linked to bladder transitional cell carcinoma.